Literature DB >> 12469199

Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1.

Masanori Kaneuchi1, Masahiro Sasaki, Yuichiro Tanaka, Noriaki Sakuragi, Seiichiro Fujimoto, Rajvir Dahiya.   

Abstract

Quercetin and other polyphenols have anti-carcinogenic and anti-tumorigenic activity in various organs, however, studies of this activity are lacking in endometrial cancer. We hypothesize that quercetin has anti-proliferative activity and the mechanisms of quercetin action may be through modulation of cell cycle and cell growth regulatory genes. To test this hypothesis, we treated endometrial cancer cells (Ishikawa cell line) with quercetin, and cell proliferation, expression of growth signal genes (EGF, VEGF, and TGF-alpha), cell cycle genes (p53, p21, p73, and cyclin D1), and apoptosis-related genes (bcl-2 and bax) were analyzed. Results of these experiments demonstrate that after a 7-day exposure to 1, 10 and 100 micro M of quercetin, growth of Ishikawa cells was inhibited by 3, 51 and 87%, respectively. The gene and protein expression data suggest that quercetin treatment (100 micro M) significantly decreased EGF and cyclin D1, whereas VEGF was up-regulated in Ishiwaka cell lines. Other genes such as TGF-alpha, p53, p21, p73, bcl-2 and bax were not significantly changed with quercetin treatment in Ishiwaka cell lines. The present study suggests that quercetin can suppress proliferation of Ishikawa cells through down-regulation of EGF and cyclin D1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12469199

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK.

Authors:  M-H Oak; J E Bedoui; S V F Madeira; K Chalupsky; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

2.  Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology.

Authors:  Lanyu Li; Lukai Yang; Fang Liu; Jinfeng Qu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-13       Impact factor: 2.650

3.  The investigation of effects of quercetin and its combination with Cisplatin on malignant mesothelioma cells in vitro.

Authors:  A Demiroglu-Zergeroglu; B Basara-Cigerim; E Kilic; G Yanikkaya-Demirel
Journal:  J Biomed Biotechnol       Date:  2010-05-17

4.  Phytochemical investigation and antimicrobial activity of Psidium guajava L. leaves.

Authors:  A M Metwally; A A Omar; F M Harraz; S M El Sohafy
Journal:  Pharmacogn Mag       Date:  2010-07       Impact factor: 1.085

5.  Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes.

Authors:  Hari Krishnan Nair; Kesava V K Rao; Ravikumar Aalinkeel; Supriya Mahajan; Ram Chawda; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

6.  Synthesis, characterisation and antitumour activity of some quercetin analogues.

Authors:  M K Gadhwal; Swati Patil; Priscilla D'Mello; Urmila Joshi; Ragini Sinha; G Govil
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

Review 7.  Honey and Cancer: Current Status and Future Directions.

Authors:  Laura M Porcza; Claire Simms; Mridula Chopra
Journal:  Diseases       Date:  2016-09-30

Review 8.  Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.

Authors:  Rajeev K Singla; Sahar Behzad; Johra Khan; Christos Tsagkaris; Rupesh K Gautam; Rajat Goyal; Hitesh Chopra; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

Review 9.  Potential of Kalanchoe pinnata as a Cancer Treatment Adjuvant and an Epigenetic Regulator.

Authors:  Marta Elena Hernández-Caballero; José Alfredo Sierra-Ramírez; Ricardo Villalobos-Valencia; Emmanuel Seseña-Méndez
Journal:  Molecules       Date:  2022-09-29       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.